Biodegradable Medical Polymers Market Report 2026

The biodegradable medical polymers market size has grown rapidly in recent years. It will grow from $2.78 billion in 2025 to $3.24 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to rising use of absorbable sutures, early adoption of biodegradable implants, expansion of orthopedic and cardiovascular procedures, advancements in polymer chemistry, increasing acceptance of resorbable materials.

The biodegradable medical polymers market size is expected to see rapid growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive procedures, rising focus on sustainable medical materials, expansion of drug-device combination products, growing investments in regenerative medicine, advancements in precision polymer engineering. Major trends in the forecast period include increasing use of bioabsorbable implant materials, rising demand for controlled degradation polymers, growing adoption of polymers in drug delivery systems, expansion of advanced biopolymer processing techniques, enhanced focus on biocompatibility and safety.

The rising demand for minimally invasive procedures is anticipated to fuel the expansion of the biodegradable medical polymers market in the future. Minimally invasive procedures involve medical techniques that employ small incisions or non-invasive approaches for surgeries or interventions, leading to less tissue damage, quicker recovery periods, and reduced postoperative discomfort relative to conventional surgical approaches. These procedures are on the rise thanks to progress in medical technology, which boosts the global uptake of precise surgical methods. Biodegradable medical polymers aid minimally invasive surgeries by facilitating temporary implants, sutures, and drug delivery devices that dissolve naturally in the body, eliminating the need for follow-up removal surgeries, lowering tissue injury, and accelerating patient healing with reduced risks. For example, in February 2023, the American Society of Plastic Surgeons - a US-based professional group - reported that cosmetic minimally invasive procedures grew from 23.7 million in 2022 to 25.4 million in 2023. Thus, the growing demand for minimally invasive procedures is propelling the biodegradable medical polymers market forward.

Major companies in the biodegradable medical polymers market are prioritizing cutting-edge technologies like biopolymer technology to boost the performance, biocompatibility, and sustainability of medical devices and drug delivery systems. Biopolymer technology involves the science and use of polymers from natural origins, crafted to biodegrade and support environmental health, and it produces sustainable materials for medical, packaging, and industrial uses while cutting dependence on synthetic plastics. For example, in November 2023, Sulzer Ltd., a Swiss public company based in Switzerland, unveiled CAPSUL, an innovative end-to-end licensed technology for continuously manufacturing polycaprolactone (PCL), a biodegradable polyester, which allows for high-quality PCL grades at cost-effective prices. This introduction seeks to advance sustainable and biodegradable materials, enhance production efficiency, and deliver premium eco-friendly polymers for medical and industrial purposes.

In July 2023, Evonik Industries AG, a Germany-based chemicals firm, purchased Novachem Corporation for an undisclosed sum. This acquisition allows Evonik to bolster its portfolio of sustainable cosmetic active ingredients by incorporating Novachem's innovative, biotech-derived, and eco-certified actives, while bolstering its System Solutions in the personal care sector across the Americas and advancing its shift toward sustainable specialties. Novachem Corporation, a Canada-based petrochemical firm, produces biodegradable medical polymers.

Major companies operating in the biodegradable medical polymers market are Evonik Industries AG, Corbion N.V., dsm-firmenich AG, Mitsui Chemicals Inc., Poly Medicure Limited, KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC.

North America was the largest region in the biodegradable medical polymers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodegradable medical polymers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biodegradable medical polymers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the biodegradable medical polymers market by increasing costs of imported raw materials, specialty monomers, processing equipment, and quality testing instruments used in polymer synthesis and fabrication. Medical device and pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported high-purity materials, while Asia-Pacific faces pricing pressure on export-oriented polymer production. These tariffs are raising production costs and impacting pricing strategies. However, they are also encouraging regional sourcing of bio-based feedstocks, domestic polymer manufacturing, and innovation in cost-efficient biodegradable material formulations.

The biodegradable medical polymers market research report is one of a series of new reports that provides biodegradable medical polymers market statistics, including biodegradable medical polymers industry global market size, regional shares, competitors with a biodegradable medical polymers market share, detailed biodegradable medical polymers market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable medical polymers industry. This biodegradable medical polymers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biodegradable medical polymers are a category of cutting-edge materials designed to break down into non-toxic byproducts in the body or environment once their medical function is fulfilled. They minimize postoperative issues, promote the body's natural recovery, and remove the necessity for surgical removal. With superior biocompatibility and precise degradation control, they play a vital role in progressing contemporary medical therapies.

The primary product types of biodegradable medical polymers include polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxyalkanoates, and others. Polylactic acid is a biodegradable thermoplastic sourced from renewable materials like corn starch and sugarcane, commonly applied in medical and packaging uses. The different material types encompass ceramic matrix composites (CMC), oxide ceramics, non-oxide ceramics, and advanced porous ceramics. The various product forms consist of powder, tiles, coatings, fibres, and bulk. These serve applications such as drug delivery, implants, sutures, and others.

The biodegradable medical polymers market consists of sales of sutures, drug delivery systems, wound dressings, orthopedic devices, dental implants, tissue engineering scaffolds, and surgical instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.